Piotr Wojdyla in Madison, Wisconsin

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1996
The Primary Medical Specialty for Piotr Wojdyla is listed as: Pulmonary Disease
Approximate Years of Experience: 28
PAC (PECOS ID)#: 0840364568
NPI #: 1750327961
NPI Created On: 06/22/2006
NPI Last Updated Listed as: 12/22/2020
Primary Taxonomy Code: 207RP1001X
License Number:
49136-020
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Dean Health Plan
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: POLISH, ENGLISH.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Ventilation assistance and management, hospital inpatient or observation
3. Measurement and graphic recording of total and timed exhaled air capacity
4. Measurement and graphic recording of total and timed exhaled air capacity
5. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
6. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
7. Determination of lung volumes using plethysmography
8. Determination of lung volumes using plethysmography
9. Measurement of lung diffusing capacity
10. Measurement of lung diffusing capacity
11. New patient office or other outpatient visit, typically 60 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Established patient office or other outpatient, visit typically 40 minutes
15. Initial hospital inpatient care, typically 70 minutes per day
16. Subsequent hospital inpatient care, typically 25 minutes per day
17. Subsequent hospital inpatient care, typically 35 minutes per day
18. Critical care delivery critically ill or injured patient, first 30-74 minutes
19. Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg